DEXCOM, INC. Equity Securities, FV-NI, Gain (Loss)
DEXCOM, INC. (DXCM) reported Equity Securities, FV-NI, Gain (Loss) of -$10.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-07-30
- DEXCOM, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2026-06-30 was -$10.00M.
- DEXCOM, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2026-03-31 was $0.00.
- DEXCOM, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2025-12-31 was $0.00.
- DEXCOM, INC. equity securities, fv-ni, gain (loss) for the quarter ending 2025-09-30 was $82.70M, a 20575.00% increase year-over-year.
- DEXCOM, INC. equity securities, fv-ni, gain (loss) for fiscal 2025 was $78.10M.
- DEXCOM, INC. equity securities, fv-ni, gain (loss) for fiscal 2024 was -$1.40M, a 173.68% decline from fiscal 2023.
- DEXCOM, INC. equity securities, fv-ni, gain (loss) for fiscal 2023 was $1.90M.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.00M 10-Q · filed 2026-07-30 | -$10.00M 10-Q · filed 2026-07-30 | -$10.00M derived: sum of 3 quarters · filed 2026-07-30 | $72.70M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-04-30 | $82.70M derived: sum of 3 quarters · filed 2026-04-30 | $82.30M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $82.70M derived: sum of 2 quarters · filed 2026-02-12 | $82.30M derived: sum of 3 quarters · filed 2026-07-30 | $78.10M 10-K · filed 2026-02-12 |
| 2025-09-30 | $82.70M 10-Q · filed 2025-10-30 | $82.30M derived: sum of 2 quarters · filed 2026-07-30 | $78.10M 10-Q · filed 2025-10-30 | $78.10M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$400.00K 10-Q · filed 2026-07-30 | -$4.60M 10-Q · filed 2026-07-30 | -$4.60M derived: sum of 3 quarters · filed 2026-07-30 | -$4.20M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$4.20M 10-Q · filed 2026-04-30 | -$4.20M derived: sum of 2 quarters · filed 2026-04-30 | -$3.80M derived: sum of 3 quarters · filed 2026-04-30 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $400.00K derived: sum of 2 quarters · filed 2026-02-12 | -$1.40M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $400.00K 10-Q · filed 2025-10-30 | -$1.40M 10-Q · filed 2025-10-30 | ||
| 2023-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.90M 10-K · filed 2026-02-12 | ||
| 2023-09-30 | $1.00M 10-Q · filed 2023-10-26 | |||
| 2022-09-30 | $200.00K 10-Q · filed 2023-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |